Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Living Cell Technologies.
RELATED STOCKHEAD STORIES
News
ASX Capital Raise Roundup: Low expectations + strong earnings =
Health & Biotech
ASX Health Stocks: Alterity moves to Phase 2 on cancer drug, Race Oncology secures 6th US patent
News
10 at 10: These ASX stocks have floated up high this morning
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
News
Weekly small cap wrap: Who received an award this week?
Health & Biotech
Check-up: Orthocell races ahead to lead the health and biotech pack
News
Rise and Shine: What you need to know before the ASX opens
News
Weekly ASX small cap wrap: who’s ready to vote tomorrow?
Rise and Shine: What you need to know before the ASX opens
News
Lunchtime ASX small cap wrap: Who doesn’t stink today?
Health & Biotech
Zoono is a $24m company. It just sold $33m worth of product
News
Lunchtime ASX small cap wrap: who just beat a giant?
Health & Biotech
Living Cell’s brain implant is still mostly working after 4 years, shares rise 15pc
Health & Biotech
Parkinson’s brain implant works for some, inflames others; Living Cell shares up 47pc
Health & Biotech
Living Cell’s Parkinson’s trial data isn’t looking so shaky; shares jump 50pc
Health & Biotech
